comprehensive -WSS

comprehensive

author：entertainment 2025-08-28 13:06:18 - browse：77845

From left: Daphne Koller, CEO of Insitro, Vijay Pande of Andreessen Horowitz and scientist Derek Lowe speaking at STAT's Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

Artificial intelligence is a rapidly improving technology. But its progress in drug development faces an increasingly urgent threat: An unending stream of overheated marketing.

To read of AI’s feats in press releases is to learn of a miracle product on the verge of unraveling biology’s most enduring secrets. It can map molecules and accurately predict how they fit together on computer screens. All you need to get to a cure — as they say in infomercials — is act now!

“I am very worried about the hype,” said Daphne Koller, chief executive of the machine learning drug discovery company Insitro, said during STAT’s Breakthrough West Summit in San Francisco last week. “People think (the breakthrough) is going to happen tomorrow.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： RaDonda Vaught case: a double standard for nurses, physicians

focus

WSS

Why 40% Americans with Parkinson’s don’t see a neurologist

N.Y. state detects polio case, first in the U.S. since 2013

Palantir health business leans on meeting customers’ needs

Can food be medicine? And other questions about a new push

How the political right came to back psychedelics to treat trauma

Biden launches a new push to limit health care costs

hotspot

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

NIH fellows want a pay raise. Will that mean less money for grants?

How one medical school became remarkably diverse

Iowa House, Senate pass 6

23andMe had bad news about my health. I wish a person had delivered it

Pfizer's Covid pill remains 89% effective in final analysis, company says

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Leqembi, other new Alzheimer’s drugs require better biomarkers

Medical leaders decry Supreme Court decision on affirmative action

It's time to get medical device identifiers over the finish line

hotspot

7 people shot in DC, police say

RaDonda Vaught case: a double standard for nurses, physicians

What to know about OceanGate, the company behind the missing Titanic submersible

Iowa House, Senate pass 6

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

Bacterial infection may be ‘key event’ in endometriosis, study says

hotspot

focus

focus

knowledge